Traduction de «Antenne directive du type à ondes progressives » (Français → Anglais) :

directional aerial of travelling wave type | directional antenna of travelling wave type

travelling-wave aerial | progressive-wave aerial

travelling-wave antenna [ progressive-wave antenna ]

helix type travelling-wave tube

progressive-wave antenna | travelling-wave antenna

progressive-wave aerial | progressive-wave antenna | travelling-wave aerial | travelling-wave antenna

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...

Of these, the only significant user in the EU is the chlor-alkali industry, but this type of emission will be progressively reduced under the IPPC Directive.

Emphasises that appropriate market arrangements must facilitate the progressive integration of RES into the energy system and the European internal energy market in all the Member States without delay and that in the long term different types of RES, in accordance with their intrinsic characteristics and capabilities, must take on stabilising functions and tasks within the system that have previously been performed by conventional ...[+++]energy sources; stresses that promising examples of such markets exist in the EU; calls, in that connection, for greater account to be taken, in planning and implementation, of the positive and negative and direct and indirect side effects of RES, in particular with regard to existing infrastructure, such as transmission and distribution systems and the environment, biodiversity and nature conservation; calls on the Commission and the Member States to raise public awareness of the potential effects of the various RES technologies;

The requirements of this guideline apply to all proponents who plan to install or modify an antenna system, regardless of the type of installation or service.